GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Yu, De cai ^a,b   Liu, Jia ^b   Chen, Jun ^a,b   Shao, Jiao jiao ^b   Shen, Xiao ^b   Xia, Hong guang ^c   Li, Chao jun ^b   Xue, Bin ^b,c   Ding, Yi tao ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; GERANYLGERANYL PYROPHOSPHATE; GGPPS1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; DIMETHYLALLYLTRANSFERASE; FARNESYL TRANS TRANSFERASE; GERANYLTRANSFERASE; GGPS1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE; GENE EXPRESSION; GGPPS1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR INVASION; WESTERN BLOTTING; YOUNG ADULT; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER TISSUE; CARCINOMA CELL; CLINICAL FEATURE; DISEASE ASSOCIATION; DONOR; HISTOPATHOLOGY; LIVER; LIVER GRAFT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; AGED; BIOSYNTHESIS; COMPLICATION; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DIMETHYLALLYLTRANSTRANSFERASE; FARNESYLTRANSTRANSFERASE; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERANYLTRANSTRANSFERASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84901235471     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-248     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005, 9(2):191-211. v, 10.1016/j.cld.2004.12.009, 15831268.
3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127(5 Suppl 1):S5-S16.
4. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51(6):1972-1978. 10.1002/hep.23527, 20209604.
5. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006, 6(9):674-687. 10.1038/nrc1934, 16929323.
6. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010, 42(Suppl 3):S206-S214. 3392755, 20547305.
7. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28(4):629-636. 10.1161/ATVBAHA.107.151092, 18174459.
8. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010, 39(1):1-7. 10.1016/j.gtc.2009.12.014, 2833287, 20202574.
9. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115(24):5651-5661. 10.1002/cncr.24687, 3397779, 19834957.
10. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010, 29(36):4989-5005. 10.1038/onc.2010.236, 20639898.
11. Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res 2010, 86(2):311-320. 10.1093/cvr/cvp375, 19946014.
12. Wasko BM, Dudakovic A, Hohl RJ. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate. J Pharmacol Exp Ther 2011, 337(2):540-546. 10.1124/jpet.110.175521, 21335425.
13. Dudakovic A, Tong H, Hohl RJ. Geranylgeranyl diphosphate depletion inhibits breast cancer cell migration. Invest New Drugs 2011, 29(5):912-920. 10.1007/s10637-010-9446-y, 20480384.
14. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990, 343(6257):425-430. 10.1038/343425a0, 1967820.
15. Vicent D, Maratos-Flier E, Kahn CR. The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob/ob mouse and induced by adipogenesis. Mol Cell Biol 2000, 20(6):2158-2166. 10.1128/MCB.20.6.2158-2166.2000, 110832, 10688662.
16. Shen N, Gong T, Wang JD, Meng FL, Qiao L, Yang RL, Xue B, Pan FY, Zhou XJ, Chen HQ, Ning W, Li CJ. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling. Am J Pathol 2011, 178(1):110-118. 10.1016/j.ajpath.2010.11.016, 3069843, 21224049.
17. Shen N, Shao Y, Lai SS, Qiao L, Yang RL, Xue B, Pan FY, Chen HQ, Li CJ. GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation. Am J Pathol 2011, 179(6):2740-2750. 10.1016/j.ajpath.2011.08.011, 3260860, 21983072.
18. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002, 2(2):133-142. 10.1038/nrc725, 12635176.
19. Calvisi DF, Ladu S, Conner EA, Seo D, Hsieh JT, Factor VM, Thorgeirsson SS. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol 2011, 54(2):311-319. 10.1016/j.jhep.2010.06.036, 3031080, 21067840.
20. Lee TK, Poon RT, Yuen AP, Man K, Yang ZF, Guan XY, Fan ST. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression. Clin Cancer Res 2006, 12(17):5082-5089. 10.1158/1078-0432.CCR-05-2794, 16951224.
21. Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T, Fan J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin Cancer Res 2012, 18(11):3042-3053. 10.1158/1078-0432.CCR-12-0183, 22512980.
22. Yu D, Sun X, Qiu Y, Zhou J, Wu Y, Zhuang L, Chen J, Ding Y. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007, 13(13):3814-3824. 10.1158/1078-0432.CCR-06-2594, 17606712.
23. Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat 1998, 5(5):285-299. 10.1046/j.1365-2893.1998.00116.x, 9795912.
24. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26(22):3291-3310. 10.1038/sj.onc.1210422, 17496923.
25. Wang D, Dou K, Xiang H, Song Z, Zhao Q, Chen Y, Li Y. Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol 2007, 22(11):1916-1920. 10.1111/j.1440-1746.2006.04534.x, 17914970.
26. Li XR, Ji F, Ouyang J, Wu W, Qian LY, Yang KY. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 2006, 32(10):1130-1134. 10.1016/j.ejso.2006.05.012, 16806792.
27. Fromigue O, Hay E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ 2006, 13(11):1845-1856. 10.1038/sj.cdd.4401873, 16470222.
28. Kenerson HL, Yeh MM, Yeung RS. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PloS One 2011, 6(3):e18075. 10.1371/journal.pone.0018075, 3066210, 21479224.
29. Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, Bronson RT, Kwiatkowski DJ, Manning BD. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal 2012, 5(217):ra24. 3743103, 22457330.
30. Chou MM, Blenis J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 1996, 85(4):573-583. 10.1016/S0092-8674(00)81257-X, 8653792.